Breaking News Instant updates and real-time market news.

FTNT

Fortinet

$34.09

-0.9 (-2.57%)

07:19
10/12/16
10/12
07:19
10/12/16
07:19

Fortinet price target lowered to $34 from $42 at Barclays

Barclays analyst Saket Kalia said Fortinet pre announced a negative Q3 due to macro weakness and sales execution in enterprise that drove a billings shortfall. The analyst said wants to hear more about competition on the earnings call and wonders how much came from subscription billings versus product. Kalia lowered Fortinet's price target to $32 from $42 and has an Overweight rating on shares.

  • 27

    Oct

  • 14

    Nov

  • 12

    Dec

FTNT Fortinet
$34.09

-0.9 (-2.57%)

09/23/16
OPCO
09/23/16
NO CHANGE
OPCO
Outperform
Speculation suggests Imperva takeover in 'near sight,' says Oppenheimer
Oppenheimer analyst Shaul Eyal is not surprised to see the list of potential Imperva (IMPV) buyer candidates mentioned in an article from Bloomberg, which includes Cisco (CSCO), IBM (IBM), Fortinet (FTNT), Akamai (AKAM), and privately held Forcepoint. The analyst envisions Imperva's product line aligning particularly well with Cisco's and IBM's given the recent drive by both to expand their security offerings. Eyal sees a potential price target ranging between $55-$60 if the speculation has any merit and sufficient interest from multiple bidders. Oppenheimer has an Outperform rating on Imperva's shares.
10/12/16
PIPR
10/12/16
NO CHANGE
Target $30
PIPR
Neutral
Piper sees Fortinet issues as company specific
Piper Jaffray analyst Andrew Nowinski believes the issues that drove Fortinet's (FTNT) negative Q3 preannouncement are company specific. He lowered his price target for the shares to $30 from $33 and keeps a Neutral rating on the name. Nowinski points out that his firm's channel checks suggest demand has remained strong for both Palo Alto Networks (PANW) and Check Point (CHKP). The analyst recommends adding to positions in both names following any pressure from the Fortinet miss.
10/12/16
JPMS
10/12/16
NO CHANGE
Target $46
JPMS
Overweight
Fortinet price target lowered to $46 from $54 at JPMorgan
JPMorgan analyst Sterling Auty lowered his price target for Fortinet to $46 following the company's negative Q3 preannouncement but keeps an Overweight rating on the name. Issues in execution, primarily in North America, impacted sales, Auty tells investors in a research note. The analyst, however, says he is standing behind his "cash flow growth thesis."
10/12/16
OPCO
10/12/16
NO CHANGE
Target $40
OPCO
Outperform
Fortinet price target lowered to $40 from $45 at Oppenheimer
Oppenheimer analyst Shaul Eyal lowered his price target for Fortinet to $40 from $45 after the company pre-announced disappointing Q3 results impacted by macroeconomic issues in Latin America and the U.K., and execution challenges relating primarily to the ongoing sales force realignment in North America. However, the analyst believes Fortinet's challenges are reversible and reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

DAL

Delta Air Lines

$48.38

0.61 (1.28%)

12:56
12/02/16
12/02
12:56
12/02/16
12:56
Hot Stocks
Ned Walker to return to Delta as chief communications officer »

John "Ned"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$32.06

-1.7901 (-5.29%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$28.99

0.465 (1.63%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Conference/Events
MGM Resorts participates in a luncheon meeting hosted by the National Press Club »

James Murren, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

VASC

Vascular Solutions

12:48
12/02/16
12/02
12:48
12/02/16
12:48
Downgrade
Vascular Solutions rating change  »

Vascular Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/02/16
12/02
12:45
12/02/16
12:45
General news
Breaking General news story  »

Week of 12/2 Baker-Hughes…

NUS

Nu Skin

$50.75

0.52 (1.04%)

12:44
12/02/16
12/02
12:44
12/02/16
12:44
Conference/Events
Nu Skin to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

, IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

12:41
12/02/16
12/02
12:41
12/02/16
12:41
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week total flows…

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

XOP

SPDR Oil Exploration and Production Fund

$41.98

-0.075 (-0.18%)

FXR

First Trust Industrials/Producer Durables AlphaDEX Fund

$33.03

0.0144 (0.04%)

GLD

SPDR Gold Trust

$112.20

0.6635 (0.59%)

IAU

iShares Gold Trust

$11.34

0.07 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

12:40
12/02/16
12/02
12:40
12/02/16
12:40
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

, JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

12:34
12/02/16
12/02
12:34
12/02/16
12:34
Periodicals
Actelion's silence speaks volumes to hedge funds, Reuters says »

Actelion's (ALIOF)…

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.51

0.0018 (0.35%)

, BSX

Boston Scientific

$20.33

0.235 (1.17%)

12:31
12/02/16
12/02
12:31
12/02/16
12:31
Recommendations
Neovasc, Boston Scientific analyst commentary  »

Neovasc's Boston…

NVCN

Neovasc

$0.51

0.0018 (0.35%)

BSX

Boston Scientific

$20.33

0.235 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

FE

FirstEnergy

$30.62

-0.37 (-1.19%)

12:30
12/02/16
12/02
12:30
12/02/16
12:30
Options
Flurry of activity in First Energy puts »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

IBERIABANK

$84.15

1.3 (1.57%)

12:26
12/02/16
12/02
12:26
12/02/16
12:26
Upgrade
IBERIABANK rating change  »

IBERIABANK upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

12:20
12/02/16
12/02
12:20
12/02/16
12:20
General news
Treasury Option Action: and now some bullish call buying »

Treasury Option Action:…

PBIB

Porter Bancorp

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp says court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
12/02/16
12/02
12:15
12/02/16
12:15
General news
Breaking General news story  »

Federal Reserve Gov.…

PBIB

Porter Bancorp

12:13
12/02/16
12/02
12:13
12/02/16
12:13
Hot Stocks
Porter Bancorp announces appellate court affirms ruling »

Porter Bancorp, parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$58.51

0.54 (0.93%)

, WDAY

Workday

$71.33

-10.275 (-12.59%)

12:12
12/02/16
12/02
12:12
12/02/16
12:12
General news
On The Fly: Top stock stories at midday »

Stocks opened with modest…

SBUX

Starbucks

$58.51

0.54 (0.93%)

WDAY

Workday

$71.33

-10.275 (-12.59%)

ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

P

Pandora

$12.58

1.095 (9.54%)

SIRI

Sirius XM

$4.56

-0.015 (-0.33%)

BX

Blackstone

$25.82

-0.33 (-1.26%)

GM

General Motors

$35.75

-0.6802 (-1.87%)

JPM

JPMorgan

$81.22

-0.57 (-0.70%)

BLK

BlackRock

$372.34

-4.86 (-1.29%)

DIS

Disney

$98.47

-0.4661 (-0.47%)

WMT

Wal-Mart

$70.74

0.0662 (0.09%)

IBM

IBM

$159.48

-0.342 (-0.21%)

INFO

IHS Markit

$35.11

-0.83 (-2.31%)

ASNA

Ascena Retail

$5.83

-0.21 (-3.48%)

FIVE

Five Below

$39.88

0.52 (1.32%)

AMBA

Ambarella

$61.39

-0.13 (-0.21%)

SWHC

Smith & Wesson

$23.98

0.65 (2.79%)

ATI

Allegheny Technologies

$16.05

-1.71 (-9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

SOHO

Sotherly Hotels

$5.48

-0.01 (-0.18%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Hot Stocks
Sotherly Hotels announces $10M stock repurchase program »

Sotherly Hotels announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$7.65

-0.09 (-1.16%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Options
Fiat Chrysler Dec 7 - 8 call spread at 64c, 4K on ISE »

Fiat Chrysler Dec 7 - 8…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

PBIB

Porter Bancorp

12:07
12/02/16
12/02
12:07
12/02/16
12:07
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.80

-0.26 (-1.62%)

12:02
12/02/16
12/02
12:02
12/02/16
12:02
Periodicals
Deutsche Bank to cease some coverage for about 3,400 clients, WSJ says »

Deutsche Bank plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

OZM

Och-Ziff Capital

$3.14

0.18 (6.08%)

12:01
12/02/16
12/02
12:01
12/02/16
12:01
Hot Stocks
Och-Ziff Capital advances after AUM increased in November »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$11.93

-0.47 (-3.79%)

12:00
12/02/16
12/02
12:00
12/02/16
12:00
Options
Third day of interest in Etsy Mar 15 calls »

Third day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.